Chris Breen Appointed as CEO for Downing Care

Investment company Downing LLP has appointed Chris Breen as chief executive of Downing Care to lead the provider’s growth and oversee its expansion into supported living.

Chris’s previous role was with Achieve together where he was Director of Operations for two years. Before this, he was Director of Operations at Priory Group.

Downing LLP has owned the operator, which provides residential care and support for adults with learning disabilities, mental health needs, and physical disabilities, for 18 years. Downing Care currently operates four properties with 37 beds in Hampshire and Surrey.

Speaking of his appointment, Chris said, ‘I’m really looking forward to taking Downing Care to the next level. Downing has a clear vision for growth in specialist care and the standard of care that these facilities provide is top of the range.’

Torsten Mack, Investment Director with Downing said,  ‘a key part of Downing’s healthcare strategy going forward is to continue to selectively invest in the specialist care space, either through Downing Care or by supporting other management teams with growth and development.

‘We intend to grow through M&A, as well as through organic growth opportunities. Service-wise, we intend to expand into supported living,’

‘We see the adult specialist care market as a market-driven by clear long term and non-cyclical growth trends, as well as being in transition. Consequently, we have also seen increasing investor interest in the sector.’

Carter Schwartz’s Managing Director Adam Carter advised on Chris Breen’s appointment.

Press Contact:

Michâela Deasy
Head of Communications
M: +44(0)7399 448 885

About Carter Schwartz

Carter Schwartz is one of the UK’s leading executive search boutiques providing an innovative range of human capital solutions for the Independent Health and Social Care, Education, Med-Tech and Life Science markets. With an impressive global reach through offices in the UK, USA and Germany, their track record of leadership appointments places them at the forefront of your growth plans when it comes to your next C-Suite, or non-executive leadership hires.

+44 (0)203 102 4835  |  |